Design and analysis of trials for assessing heterogeneity of individual treatment effect

Vipin Arora Chair
Eli Lilly and Company
 
Mark Rothmann Panelist
 
Daniel Beavers Panelist
Wake Forest University
 
Changyu Shen Panelist
Biogen
 
David Allison Panelist
Children's Nutrition Research Center, Baylor College of Medicine
 
Peipei Shi Panelist
AstraZeneca
 
Vipin Arora Organizer
Eli Lilly and Company
 
Monday, Aug 4: 2:00 PM - 3:50 PM
0163 
Invited Panel Session 
Music City Center 
Room: CC-104C 

Presentations

Description

Panelists to share thoughts along the following:

Design and analysis of trials for assessing heterogeneity of individual treatment.

Multiple perspectives e.g., pooling trials for studying heterogeneity, Bayesian approaches to measuring and quantifying TRH, or the role of testing variances (SDIR) to determine if TRH exists.

Treatment heterogeneity, from a meta-analytic standpoint.

Precision improvement in estimating treatment effect through novel summary measure, baseline-covariate adjustment/imputation strategy and taking advantages of features of disease progression.

Applied

Yes

Main Sponsor

Section for Statistical Programmers and Analysts

Co Sponsors

Biopharmaceutical Section
Caucus for Women in Statistics